Plant pathogens and pests are increasingly resistant to common pesticides and herbicides. Resurrect Bio uses gene editing to repair plants’ natural defenses. Its products are designed for mass-produced crops like soy, corn and wheat. It’s also developing options for cotton and cruciferous vegetables, which include broccoli, cauliflower and kale.
The London-based company’s Series A equity round was led by Corteva Catalyst, the investment arm of Corteva Agriscience, which spun out of DowDuPont several years after the two agrichemicals giants merged. Dutch impact investor Pymwymic, the UK Innovation and Science Seed Fund, SynBioVen and AgFunder also participated.
Resurrect Bio will use the capital to develop its AI-enabled screening tool, FloraFold, which identifies disease-resistant genes in plants.
